← Leaderboards
Ashley S. Felix
Ohio State University
$2,667,435
Attributed
$2,667,435
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $580.4K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,667,435 · 3
By mechanism
R37$1,808,695 · 1
K01$702,740 · 1
R03$156,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Paul Martin Coen$5,768,130
- Patricia A. Ganz$11,268,092
- Theodore M. Brasky$1,141,251
- Macarius M. Donneyong$2,664,701
- Ai Ni$1,685,864
Others in their field
Other Emerging Leaders on “Literature”
- John Damon Chodera · Sloan-Kettering Inst Can Research$40,089,510
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Stephen Wilson · La Jolla Institute For Immunology$11,742,477
- Carla M Bann · Research Triangle Institute$11,018,358
- Kristen Jacklin · University Of Minnesota$9,029,940
- Alan James Bridge · European Molecular Biology Laboratory$8,787,716
Research focus
LiteratureFuturePathologyWomanEndometrial CarcinomaOperative Surgical ProceduresLinkBaseTherapy DevelopmentRaceAffectSubgroupMalignant NeoplasmsUnited StatesMalignant Female Reproductive System NeoplasmStagingProspectiveHealth DisparityGuidelinesHigh RiskCancer PatientRacial DifferenceBiologicalBody Weight Decreased
Grant awards (12)
Understanding multilevel drivers of gaps in guideline-concordant endometrial cancer treatment in high-risk populations$580,415
R37 · FY2025 · CA · contact PI
Multilevel determinants of racial disparities in receipt of guideline-concordant endometrial cancer treatment$365,082
R37 · FY2024 · CA · contact PI
Multilevel determinants of racial disparities in receipt of guideline-concordant endometrial cancer treatment$476,128
R37 · FY2023 · CA · contact PI
Multilevel determinants of racial disparities in receipt of guideline-concordant endometrial cancer treatment$387,070
R37 · FY2022 · CA · contact PI
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$133,625
K01 · FY2022 · CA · contact PI
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$133,625
K01 · FY2021 · CA · contact PI
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$133,625
K01 · FY2020 · CA · contact PI
Determining the clinical significance of intraluminal tumor cells in endometrial cancer$78,000
R03 · FY2020 · CA · contact PI
Administrative Supplement:Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$34,615
K01 · FY2020 · CA · contact PI
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$133,625
K01 · FY2019 · CA · contact PI
Determining the clinical significance of intraluminal tumor cells in endometrial cancer$78,000
R03 · FY2019 · CA · contact PI
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer$133,625
K01 · FY2018 · CA · contact PI